Andere talen Syncona Limited

Aandelen

BACT

GG00B8P59C08

Holdingvennootschappen

Beurs gesloten - London S.E. Andere beurzen 17:35:25 15-12-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
95,90 ^GBX	0,00%		-0,10%	-9,19%

30/11	Syncona Limited, H1 2026 Earnings Call, Nov 13, 2025
13/11	Syncona ziet groeikansen in biotech ondanks daling van nettovermogenswaarde	AN

Andere talen

Syncona : IOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new non-clinical data at ASH	08/12
Syncona says positioned for biotech growth after net asset value fall	13/11
Syncona posts HY net assets of 1,020.9 mln stg	13/11
Syncona Limited Reports Earnings Results for the Half Year Ended September 30, 2025	13/11
EEnergy expands agreement; ACG Metals fundraise	12/11
Syncona : Slingshot Therapeutics strengthens team by appointing John Isaac as Chief Scientific Officer and Bobby Soni as Chief Business Officer	04/11
Syncona to focus on realisations to return GBP250 million	21/10
Syncona to Return GBP250 Million to Shareholders; Plans New Fund for Life Sciences Investment	21/10
FTSE rises as UK borrowing hits five-year high	21/10
FTSE rises as UK borrowing hits five-year high	21/10
Syncona to invest up to 5% of NAV in early-stage companies	21/10
Syncona : Mosaic Therapeutics appoints Thomas Fuchs as CEO	20/10
Syncona : IOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO	14/10
Syncona : Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress	07/10
Syncona : Yellowstone Biosciences Appoints James (“Jim”) MacDonald as Chief Executive Officer	16/09
Syncona : IOnctura Expands Roginolisib Trials to the US, Advancing Multi-Indication Strategy in Oncology	09/09
Gem Resources raises funds; Afentra Angolan progress	04/09
Syncona net asset value rises as strategy consultation continues	07/08
Syncona Reports Stable Fiscal Q1 Net Assets	07/08
Syncona : Resolutions re Shares	05/08
Syncona Limited Announces Board Changes	05/08
Syncona : OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025	07/07
Syncona : Notice of the 2025 Annual General Meeting	02/07
Syncona Limited Auditor Raises 'Going Concern' Doubt	02/07
UBS cuts Hays and PageGroup to 'neutral'	20/06

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Syncona Limited

Aandelen

BACT

GG00B8P59C08

Holdingvennootschappen

Andere talen

Filters